Introduction {#s1}
============

Shoulder-hand syndrome (SHS) is a common condition among people who have had a stroke, with its reported prevalence ranging from 12% to 49% ([@B1], [@B2]). The main symptoms of SHS include pain, hyperalgesia, joint swelling and limitations in range of motion (ROM) ([@B3]). Post-stroke SHS is also named type I complex regional pain syndrome (CRPS) or reflex sympathetic dystrophy ([@B4]). The key to effectively treating SHS is believed to be an expert multidisciplinary team that provides individualized therapy ([@B5]). There is a wide range of treatment options available to help manage post-stroke SHS, including physical therapy, medications, regional anesthesia techniques and neuromodulation. However, there is insufficient evidence to support their efficacy ([@B5]).

Acupuncture, one of the most popular traditional Chinese medicine therapies, has been widely used in the clinical management of stroke ([@B6]). Several systematic reviews have assessed its efficacy for improving stroke rehabilitation using outcomes in motor function recovery and disability, but results are inconsistent ([@B7]--[@B11]). Three reviews published before 2010 showed acupuncture did not improve motor function or dependency outcomes after rehabilitation ([@B8], [@B9], [@B11]). However, two more recently published reviews suggested acupuncture might aid rehabilitation in several areas, including motor function recovery and pain relief ([@B7], [@B10]).

Three systematic reviews specifically evaluating acupuncture for post-stroke SHS have been published ([@B12]--[@B14]). Two of these were published before 2013 ([@B12], [@B13]), so they don\'t include recently published clinical evidence. Moreover, one review including three studies did not perform quantitative synthesis due to clinical heterogeneity ([@B13]). The third review ([@B14]) does not evaluate the effectiveness of electro-acupuncture, and only two of its included studies evaluated the effectiveness of acupuncture combined with routine care. Considering electro-acupuncture is commonly used in the clinical management of stroke complications, the implication of the review results ([@B14]) for clinical practice is limited. Therefore, we conducted this systematic review looking at the most recent evidence of acupuncture (including electro-acupuncture) as an additional therapy in the clinical management of post-stroke SHS.

Methods {#s2}
=======

Study Design
------------

This systematic review included randomized controlled trials (RCT) or quasi-RCTs that were published in English or Chinese and evaluated acupuncture\'s effects as an additional therapy for post-stroke SHS. Quasi-RCTs were evaluated using the same methods applied to RCTs.

We registered its protocol with the PROSPERO international prospective register of systematic reviews (CRD 42016050446).

Participants
------------

We limited participants to people who were diagnosed with post-stroke SHS. The stroke (ischemic or hemorrhagic) diagnosis needed to be confirmed by computer tomography or magnetic resonance imaging. The SHS or CRPS type I diagnosis was based on clinical symptoms, including pain, motor disturbances and skin changes ([@B3]).

Intervention
------------

We included RCTs or quasi-RCTs that evaluated the effects of manual or electro-acupuncture combined with routine care or rehabilitation as the experimental intervention in this review. Studies that assessed auricular acupuncture or other types of recently developed acupuncture forms, such as floating acupuncture, were excluded from this review.

The rehabilitation therapy used in RCTs or quasi-RCTs could be a combination of physiotherapy and occupational therapy, such as active ROM, passive ROM, mirror visual feedback, Bobath therapy, alternating heat and cold baths, and massage. The comparator was the same as the rehabilitation therapy used in the intervention group, but without acupuncture. Studies that used placebo or sham acupuncture and the same rehabilitation therapy in the control group were also eligible for inclusion.

Outcome
-------

RCTs or quasi-RCTs that reported validated SHS outcome measures as below were considered for inclusion in this review.

Primary outcome measures: (1) motor function: Fugl-Meyer Assessment (FMA) upper limb; (2) pain assessment using visual analog scale (VAS) or numerical rating scale (NRS).

Secondary outcome measures: (1) Barthel Index (BI) or Modified Barthel Index (MBI), which is assessed for self-care and activities of daily living; (2) ROM; and (3) adverse events.

Literature Search
-----------------

We searched nine databases, five in English, and four in Chinese languages, from their inceptions to January 2019. They are: PubMed, Embase, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Cochrane Central Register of Controlled Trials (CENTRAL), the Allied and Complementary Medicine Database (AMED), China BioMedical Literature (CBM), China National Knowledge Infrastructure (CNKI), Chonqing VIP (CQVIP), and Wanfang. We also searched clinical trial registration agencies, including the Chinese Clinical Trial Registry and National Institutes of Health Register (Clinical Trials.gov), and hand-searched references lists of included studies and relative systematic reviews. The search terms and search strategy we used are presented in [Appendix S1](#SM2){ref-type="supplementary-material"}.

Data Extraction
---------------

Two researchers (SL, YC) independently screened the titles, abstracts and full text of studies to assess eligibility. Any uncertainty was resolved through discussion with CZ. SL and YC developed a standardized data extraction file using Epidata software 3.1 (The EpiData Association, Odense, Denmark, 2003--2008). They also extracted data independently and cross-checked it for accuracy. Extracted data included: author, publication year, diagnostic criteria, duration of disease, sample size, participants\' age, details of interventions and all clinical outcomes.

Risk of Bias and Certainty of Evidence Assessment
-------------------------------------------------

Two researchers (SL, YC) used the Cochrane risk of bias tool to assess the methodological quality of the included studies. They assessed seven items: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessors, incomplete outcome data, selective reporting, and other sources of bias. The studies were judged as having a "low," "high," or "unclear" risk of bias. SL and YC resolved any difference in their assessment of a study by discussing it with a third researcher (CZ).

The Grading of Recommendations Assessment, Development and Evaluation Approach (GRADE) was used to evaluate the certainty of evidence. Five items involving risk of bias, inconsistency, imprecision, indirectness and publication bias were investigated for the clinical important outcomes.

Data Analysis
-------------

The included studies calculated acupuncture\'s safety and efficacy when combined with rehabilitation to treat SHS, compared to rehabilitation alone. Data analyses were performed in a random-effects model using the RevMan software (version 5.3). Dichotomous data was reported as relative risk (RR) with corresponding 95% confidence intervals (CI). For continuous data, the mean difference (MD) with 95% CI was calculated.

The following subgroup analyses were planned: (1) subgroups of manual or electro-acupuncture; (2) subgroups of treatment duration ≤4 or \>4 weeks. Since an inappropriate randomization sequence generation was associated with biased intervention effects ([@B15]), we conducted a sensitivity analysis to check the robustness of the results by only including the RCTs that were assessed as "low" risk of bias for this item.

Results {#s3}
=======

Descriptions of Studies
-----------------------

We identified 36 eligible studies ([@B16]--[@B51]) by searching Chinese and English databases up to March 2017. An updated search, including studies from 2017 to January 2019, located another two studies that met the inclusion criteria ([@B52], [@B53]). As a result, 38 RCTs involving 3,184 participants were included in this review ([Figure 1](#F1){ref-type="fig"}).

![PRISMA flow chart.](fneur-10-00433-g0001){#F1}

As reported by the included studies, SHS occurred after ischemic stroke in four studies ([@B40], [@B42], [@B44], [@B45]), and after hemorrhagic or ischemic stroke in 23 studies. The remaining 11 studies ([@B17]--[@B19], [@B23], [@B28], [@B30], [@B31], [@B41], [@B46], [@B47], [@B50]) did not include information about the type of stroke. The duration of stroke ranged from 10 days ([@B46]) to 19 months ([@B17]). The severity of SHS was reported by 27 studies and divided into acute-hyperaemic (stage I), dystrophic-ischaemic (stage II) and atrophic (stage III) according to clinical symptoms ([@B54]). Twenty studies recruited participants at stage I with mild symptoms of \<3 months of SHS. The remaining seven studies included participants with stage II or III.

All of the eligible trials compared body acupuncture plus routine rehabilitation with routine rehabilitation alone. Of all, 12 studies also applied electrical stimulation with acupuncture ([@B16]--[@B18], [@B20], [@B21], [@B32], [@B34], [@B36]--[@B39], [@B46]). The most commonly used acupuncture points were LI15 *Jianyu*, LI11 *Quchi*, TE5 *Waiguan*, LI4 *Hegu*, TE14 *Jianliao*, LI10 *Shousanli*, HT1 *Jiquan*, PC6 *Neiguan*, and SI9 *Jianzhen*. Routine rehabilitation included active ROM, passive ROM, mirror visual feedback, Bobath therapy, alternating heat and cold baths, and massage. Treatment duration ranged from 2 to 8 weeks. None of the included studies involved a follow-up phase to investigate acupuncture\'s long-term effects.

Thirty-four studies used FMA to evaluate acupuncture\'s effects on upper limb motor function. Pain severity was assessed with VAS in 26 studies. None of the included studies reported NRS. For secondary outcomes, 11 studies reported BI or MBI, six studies reported ROM, and five studies reported adverse events ([Table 1](#T1){ref-type="table"}).

###### 

Basic characteristics.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **References**            **Sample size**   **Stroke type**                      **SHS severity**   **Duration of condition**   **First stroke onset**   **Intervention**      **Comparisons**   **Acupoints**                                                             **Acupuncture treatment details**   **Treatment duration**   **Outcome measures**
  ------------------------- ----------------- ------------------------------------ ------------------ --------------------------- ------------------------ --------------------- ----------------- ------------------------------------------------------------------------- ----------------------------------- ------------------------ ----------------------
  Chen ([@B32])             96/85             Cerebral infarction and hemorrhage   NS                 NS                          NS                       EA + Rehab            Rehab             EX-B2, GB21, SI11, LI15, TE14, SI9, LI14, PC3, LU5, TE5, SI3, LI4, HT1    Once/d, 6 d/w                       4 w                      FMA

  Chen et al. ([@B51])      48/46             Cerebral infarction and hemorrhage   Stage I            I: 34.91 d;\                Yes                      Acupuncture + Rehab   Rehab             LI15, TE14, Jianqian, SI9, LI11, TE5, LI10, EX-UE9                        30 min, once/d, 6 d/w               4 w                      FMA, VAS, BI
                                                                                                      C: 35.41 d                                                                                                                                                                                                                          

  Duan et al. ([@B17])      60/60             NS                                   NS                 14 d−19 m                   NS                       EA + Rehab            Rehab             SI11, SI9, SI10, LU2, LI11, LI10, HT3, Jianqian, Jianfeng, Ashi point     20 min, once/d, 5 d/w               8 w                      FMA

  Feng and Ma ([@B50])      69/57             NS                                   Stage I            33.1 d                      NS                       Acupuncture + Rehab   Rehab             PC6, LI5, ST9, LU5, HT1                                                   30 min, once/d                      4 w                      FMA, VAS, ROM

  Gao et al. \[2011^16^\]   16/16             Cerebral infarction and hemorrhage   NS                 48.5 d                      NS                       EA + Rehab            Rehab             LI15, TE14, LI14, LI11, TE5, TE4, KI15, EX-UE9                            30 min, once/d                      4 w                      VAS, BI

  He and Gao ([@B49])       60/60             Cerebral infarction & hemorrhage     Stage I            I: 21.07 d;\                NS                       Acupuncture + Rehab   Rehab             CV12, CV4, ST24, ST26, Shangfengshidian, Shengfengshiwaidian              30 min, once/d                      3 w                      FMA, VAS, MBI
                                                                                                      C: 20.32 d                                                                                                                                                                                                                          

  Hou ([@B20])              30/30             Cerebral infarction and hemorrhage   Stage I            I: 29.8 d;\                 NS                       EA + Rehab            Rehab             GV20, GV24, EX-HN3, LI11, TE5, LI4                                        50--100 Hz, 30 min, once/d, 5 d/w   4 w                      FMA, VAS
                                                                                                      C: 31.5 d                                                                                                                                                                                                                           

  Huang et al. ([@B48])     30/30             Cerebral infarction and hemorrhage   Stage I            I: 46.8 d;\                 Yes                      Acupuncture + Rehab   Rehab             EX-UE9, EX-UE8                                                            20 min, once/d, 5 d/w               3 w                      FMA
                                                                                                      C: 45.4 d                                                                                                                                                                                                                           

  Jia et al. ([@B21])       28/24             Cerebral infarction and hemorrhage   Stage I            I: 28.5 d;\                 NS                       EA + Rehab            Rehab             GV20, GV24, EX-HN3, LI15, TE14, LI11, TE5, LI4                            50--100 Hz, 30 min, once/d, 5 d/w   4 w                      FMA, VAS
                                                                                                      C: 31 d                                                                                                                                                                                                                             

  Li ([@B18])               60/60             NS                                   NS                 NS                          NS                       EA + Rehab            Rehab             LI1, LI2, LI3, LI5, LI11,                                                 2--30 Hz, 15 min, once/d            14 d                     FMA

  Li and Tu ([@B34])        45/45             Cerebral infarction and hemorrhage   Stage I            I: 4.29 m;\                 Yes                      EA + Rehab            Rehab             LI10, LI15, LI15, LI11, PC6, TE5, LI4, Ashi point                         50--100 Hz, 30 min, once/d, 5 d/w   6 w                      FMA, VAS, MBI
                                                                                                      C: 3.93 m                                                                                                                                                                                                                           

  Li et al. ([@B47])        46/46             NS                                   NS                 NS                          NS                       Acupuncture + Rehab   Rehab             LU9, ST36, LI11, LI10, LI15, GB39, BL62                                   30 min, once/d, 6 d/w               1 m                      FMA

  Liang and Liu ([@B46])    42/42             NS                                   Stage I, II        I: 10 d−3 m;\               NS                       EA + Rehab            Rehab             GB21, LI15, SI9, TE14, LI14, SI11, LI11, TE5, SI3, PC8, LI4               30 min, once/ d                     30 d                     FMA, VAS
                                                                                                      C: 15 d−3 m                                                                                                                                                                                                                         

  Liao ([@B33])             45/45             Cerebral infarction and hemorrhage   NS                 I: 48.6 d;\                 NS                       Acupuncture + Rehab   Rehab             GV26, PC6, HT5, HT1, ST36, GB39, SP6,LI15, LI4, LI11, TE13, TE9           30 min, once/d                      5 w                      FMA, VAS, MBI
                                                                                                      C: 50.7 d                                                                                                                                                                                                                           

  Lin et al. ([@B30])       40/40             NS                                   Stage I            I: 29.3 d;\                 NS                       Acupuncture + Rehab   Rehab             Piantan, Jiantong, Shengti, Jiansanzhen, Ashi point, HT1, PC6, LU5        30 min, once/d                      4 w                      FMA, VAS
                                                                                                      C: 28.6 d                                                                                                                                                                                                                           

  Liu ([@B23])              40/40             NS                                   NS                 I: 36.25 d;\                NS                       Acupuncture + Rehab   Rehab             Jiantong                                                                  30 min, once/d, 5 d/w               40 d                     FMA, VAS, ROM
                                                                                                      C: 37.25 d                                                                                                                                                                                                                          

  Liu and Zhang ([@B52])    49/49             Cerebral infarction and hemorrhage   NS                 I: 48.18 d;\                Yes                      Acupuncture + Rehab   Rehab             LI15, LI11, TE5, LI4, SI3, TE3                                            20 min, once/d, 6 d/w               4 w                      FMA, VAS
                                                                                                      C: 47.18 d                                                                                                                                                                                                                          

  Qin et al. ([@B27])       40/40             Cerebral infarction and hemorrhage   Stage I            I: 4 m;\                    Yes                      Acupuncture + Rehab   Rehab             Four points in head                                                       30 min, once/d, 6 d/w               NS                       VAS
                                                                                                      C: 4 m                                                                                                                                                                                                                              

  Shang et al. ([@B28])     40/40             NS                                   Stage I, II        I: 5.23 m;\                 NS                       Acupuncture + Rehab   Rehab             LI15, Jianqian, TE14, HT1, LI14, LI11, PC6, LI4                           40 min,2 times/d                    30 d                     FMA, ROM
                                                                                                      C: 5.02 m                                                                                                                                                                                                                           

  Su et al. ([@B24])        22/21             Cerebral infarction and hemorrhage   Stage I, II        I: 44.2 d;\                 NS                       Acupuncture + Rehab   Rehab             Piantan, Jiantong, Shengti                                                once/d                              2 w                      FMA
                                                                                                      C: 43.7 d                                                                                                                                                                                                                           

  Tang et al. ([@B45])      30/30             Cerebral infarction                  Stage I            I: 48.54 d;\                NS                       Acupuncture + Rehab   Rehab             SI11, LI15, LI14, Jianqian, KI15, SI3                                     40 min, 6 d/w                       28 d                     FMA, VAS
                                                                                                      C: 49.12 d                                                                                                                                                                                                                          

  Wan et al. ([@B25])       40/40             Cerebral infarction and hemorrhage   Stage I, II        I: 24.53 d;\                NS                       Acupuncture + Rehab   Rehab             Piantan, Jiantong, Bitong, Wantong                                        once/d, 5 d/w                       4 w                      FMA, MBI
                                                                                                      C: 24.4 d                                                                                                                                                                                                                           

  Wan et al. ([@B29])       60/60             Cerebral infarction and hemorrhage   Stage I, II        I: 38.4 d;\                 NS                       Acupuncture + Rehab   Rehab             LU9, ST36, GB39, TE5, LI10, LI11, LI15                                    30 min, once/d                      28 d                     FMA
                                                                                                      C: 33.0 d                                                                                                                                                                                                                           

  Wang et al. ([@B31])      31/31             NS                                   NS                 I: 10--26 d;\               NS                       Acupuncture + Rehab   Rehab             Ashi point, LI15, Jianqian, SI9, HT1, LU5, LI10, LI11, PC6, TE5, LI4      30 min, once/d, 5 d/w               5 w                      MBI
                                                                                                      C: 12--29 d                                                                                                                                                                                                                         

  Wang et al. ([@B53])      71/71             Cerebral infarction and hemorrhage   StageI, II, III    I: 66.8 d;\                 NS                       Acupuncture + Rehab   Rehab             LI15, TE14, GB21, SI9, LI17, LI11, TE5, LI4, SI6, KI15, CV6, ST36         15 min, once/d                      21 d                     FMA, MBI
                                                                                                      C: 67.4 d                                                                                                                                                                                                                           

  Wu ([@B39])               30/30             Cerebral infarction and hemorrhage   Stage I            15 d−3 m                    NS                       EA + Rehab            Rehab             EX-B2, TE14, TE13, LI15, LI14, SI9, HT1, LI4, LI11, KI15, TE5, SI6, SI3   30 min, once/d, 6 d/w               4 w                      ROM

  Xie ([@B40])              30/30             Cerebral infarction                  NS                 15 d−3 m                    NS                       Acupuncture + Rehab   Rehab             Tousanzhen, Jiansanzhen, HT1, LU5, PC6                                    once/d, 5 d/w                       4 w                      FMA, VAS, AE

  Xu ([@B36])               36/36             Cerebral infarction and hemorrhage   Stage I            I: 5--44 d;\                NS                       EA + Rehab            Rehab             LI1, LI2, LI3, LI5, LI11                                                  30 min, once/d, 6 d/w               4 w                      FMA, VAS, AE
                                                                                                      C: 4--47 d                                                                                                                                                                                                                          

  Xu et al. ([@B19])        42/40             NS                                   Stage I            I: 33.45 d;\                NS                       Acupuncture + Rehab   Rehab             Jiansanzhen, HT1, LU5, PC6                                                30 min, once/d, 6 d/w               5 w                      VAS, FMA, ROM, AE
                                                                                                      C: 27.14 d                                                                                                                                                                                                                          

  Xu et al. ([@B44])        40/40             Cerebral infarction                  Stage I            I: 47.2 d;\                 Yes                      Acupuncture + Rehab   Rehab             LI15, LI14, HT1, Jianqian, Jianhou, KI15, SI3                             40 min                              14 d                     FMA, VAS
                                                                                                      C: 48.6 d                                                                                                                                                                                                                           

  Yang et al. ([@B43])      40/40             Cerebral infarction and hemorrhage   Stage I            I: 87.93 d;\                NS                       Acupuncture + Rehab   Rehab             LI15, LI11, LI10, PC6, LI4                                                30 min, once/d                      20 d                     FMA, VAS
                                                                                                      C: 95.8 d                                                                                                                                                                                                                           

  Yin et al. ([@B26])       30/30             Cerebral infarction and hemorrhage   Stage I            I: 67.17 d;\                NS                       Acupuncture + Rehab   Rehab             Six meridians on hand, including LI15, LI11, TE14, GB21, etc.             20--30 min, once/d, 6 d/w           4 w                      FMA, VAS
                                                                                                      C: 67.10 d                                                                                                                                                                                                                          

  You ([@B37])              31/31             Cerebral infarction and hemorrhage   Stage I, II, III   I: 31.89 d;\                NS                       EA + Rehab            Rehab             LI15, TE14, SI9, LI14, SI11, LI10, TE5, LI4, EX-UE9                       30 min, once/d, 6 d/w               4 w                      FMA, VAS, MBI, ROM
                                                                                                      C: 33.45 d                                                                                                                                                                                                                          

  Zhang ([@B38])            30/30             Cerebral infarction and hemorrhage   Stage I            I: 58.64 d;\                NS                       EA + Rehab            Rehab             LI15, LI11, LI4, TE5, LI10                                                30 min, once/d, 5 d/w               3 w                      FMA, VAS, AE
                                                                                                      C: 54.97 d                                                                                                                                                                                                                          

  Zhao ([@B42])             24/23             Cerebral infarction                  Stage I            I: 77.67 d;\                Yes                      Acupuncture + Rehab   Rehab             TE14, SI9, Jianqian, LI15, Ashi point, LI11, LI5, TE5                     30 min, once/d, 6 d/w               28 d                     FMA, VAS, MBI, AE
                                                                                                      C: 65.65 d                                                                                                                                                                                                                          

  Zheng et al. ([@B35])     39/38             Cerebral infarction and hemorrhage   Stage I            I: 41.72 d;\                NS                       Acupuncture + Rehab   Rehab             LI15, TE14, SI9, LI11, LI10, TE5, LI4, SI3                                30 min, once/d, 5 d/w               4 w                      FMA, VAS, BI
                                                                                                      C: 42.48 d                                                                                                                                                                                                                          

  Zhong et al. ([@B41])     30/30             NS                                   Stage I            I: 28.4 d;\                 NS                       Acupuncture + Rehab   Rehab             Piantan, Jiantong, Shengti, Jiansanzhen, Ashi point, HT1, PC6, LU5        30 min, once/d                      30 d                     FMA, VAS
                                                                                                      C: 29.2 d                                                                                                                                                                                                                           

  Zhou et al. ([@B22])      45/45             Cerebral infarction and hemorrhage   NS                 I: 55.13 d;\                NS                       Acupuncture + Rehab   Rehab             LI4, LU7, LI11, LI15, CV21, CV4                                           30 min, once/d, 6 d/w               1 m                      FMA, VAS
                                                                                                      C: 57.08 d                                                                                                                                                                                                                          
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*All included articles were published in Chinese journals. AE, adverse events; BI, Barthel Index; C, comparison; d, day; EA, electroacupuncture; FMA, Fugl-Meyer Assessment (upper limb); I, intervention; m, month; MBI, Modified Barthel Index; NS, not specified; Rehab, rehabilitation; ROM, shoulder range of motion; VAS, visual analog scale; w, week; SHS, shoulder-hand syndrome*.

Risk of Bias of Included Studies
--------------------------------

Seventeen studies (45%) were assessed as "low" risk of bias for sequence generation, and the remaining studies were assessed as "unclear" risk due to a lack of information. Only one study ([@B38]) used opaque envelopes to conceal the allocation procedure, so it was assessed as "low" risk of bias for this item. Blinding of participants and acupuncturists was not performed in any study. Blinding of outcome assessors was assessed as "unclear" risk of bias for all studies due to a lack of information. We also assessed selective outcome reporting as "unclear" risk of bias for all studies, because none of the studies had published their protocols. For incomplete outcome data, we assessed all studies as "low" risk of bias because there was no missing outcome data. Eleven studies ([@B18], [@B19], [@B24]--[@B27], [@B29], [@B32], [@B43], [@B48], [@B52]) reported the funding source and showed balanced baseline data, so we assessed the relative other bias as "low" risk. Details are summarized in [Figure 2](#F2){ref-type="fig"} and [Figure S1](#SM1){ref-type="supplementary-material"}.

![Risk of bias of each study.](fneur-10-00433-g0002){#F2}

Acupuncture\'s Effects on Post-stroke SHS
-----------------------------------------

### FMA (Upper Limb)

Thirty-four studies reported data on upper limb FMA scores when acupuncture was combined with rehabilitation compared to rehabilitation alone. Meta-analysis of 29 studies showed the combination therapy had a significant superior effect (MD: 8.01, 95% CI \[6.69, 9.33\]; *I*^2^ = 78%). We did not include the remaining five studies ([@B17], [@B18], [@B32], [@B33], [@B48]) in our analysis due to their inappropriate data reporting: three studies ([@B18], [@B33], [@B48]) only reported scores of certain items without the total score, one study ([@B32]) reported FMA as categorical data, and one study ([@B17]) did not report FMA data for the control group.

### VAS

Compared with routine rehabilitation alone, acupuncture combined with routine rehabilitation showed superior effects on VAS scores in 25 studies (MD: −1.59, 95% CI \[−1.86, −1.32\]; *I*^2^ = 87%). We excluded one study ([@B27]) in the meta-analysis because its data was reported with median and interquartile ranges.

### ADL

Eleven studies reported acupuncture\'s effects on ADL performance, as measured by the Barthel Index (BI) or Modified Barthel Index (MBI). Meta-analysis showed that acupuncture combined with routine rehabilitation enhanced ADL performance more than rehabilitation alone did (MD: 9.99, 95% CI \[5.91, 14.06\]; *I*^2^ = 86%).

### ROM

Acupuncture combined with routine rehabilitation improved shoulder abduction by an average of 11.94 degrees (three studies ([@B19], [@B23], [@B37]): 95% CI \[9.44, 14.45\]; *I*^2^ = 0%), shoulder internal rotation by 18.72 degrees (one study ([@B37]): 95% CI \[9.63, 27.81\]), and shoulder external rotation by 15.73 degrees (one study ([@B37]): 95% CI \[6.82, 24.64\]), when compared with rehabilitation alone.

### Subgroup Analysis and Sensitivity Analysis

Subgroup analysis was conducted to examine whether adding electrical stimulation to manual acupuncture will affect primary outcomes. Manual and electro-acupuncture combined with routine rehabilitation improved FMA and pain VAS outcomes more than rehabilitation alone did ([Figures 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}). The effect of electro-acupuncture (MD 9.08, 95% CI \[6.81, 11.35\]) seems greater in magnitude than manual acupuncture (MD 7.80, 95% CI \[6.30, 9.30\]) for improving upper limb motor function, however, there was not any direct analysis to compare electro-acupuncture with manual acupuncture in this research.

![Forest plot of FMA.](fneur-10-00433-g0003){#F3}

![Forest plot of VAS.](fneur-10-00433-g0004){#F4}

Further subgroup analyses in the manual or electro-acupuncture group looked at the impact of treatment duration on outcomes. We found that treatment duration (≤4 weeks or \>4 weeks) did not significantly change the outcome. However, the number of studies included in each subgroup was relatively small ([Table 2](#T2){ref-type="table"}).

###### 

Subgroup analysis and sensitivity analysis.

  **Analysis**                                                                         **FMA (upper limb) (number of studies, number of participants in intervention/control group, mean difference, 95% CI, *I*^**2**^)**   **VAS (number of studies, number of participants in intervention/control group, mean difference, 95% CI, *I*^**2**^)**
  ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------
  **Acupuncture** **+** **rehabilitation vs. rehabilitation**                          22, 935/916, 7.80 \[6.30, 9.30\], 78%                                                                                                 17, 701/683, −1.62 \[−1.97, −1.28\], 90%
  Treatment duration ≤ 4 weeks[^a^](#TN1){ref-type="table-fn"}                         16, 692/675, 7.79 \[6.02, 9.57\], 77%                                                                                                 12, 499/483, −1.60 \[−2.02, −1.17\], 90%
  Treatment duration \> 4 weeks[^a^](#TN1){ref-type="table-fn"}                        6, 243/241, 7.74 \[5.04, 10.43\], 62%                                                                                                 5, 202/200, −1.68 \[−2.34, −1.03\], 89%
  Reported appropriate randomized allocation methods[^b^](#TN2){ref-type="table-fn"}   12, 480/476, 7.64 \[6.09, 9.18\], 40%                                                                                                 12, 465/461, −1.73 \[−2.18, −1.27\], 91%
  **Electroacupuncture** **+** **rehabilitation vs. rehabilitation**                   7, 242/238, 9.08 \[6.81, 11.35\], 48%                                                                                                 8, 258/254, −1.50 \[−1.84, −1.17\], 43%
  Treatment duration ≤ 4 weeks[^a^](#TN1){ref-type="table-fn"}                         5, 155/151, 8.46 \[6.18, 10.75\], 0%                                                                                                  6, 171/167, −1.57 \[−1.97, −1.18\], 37%
  Treatment duration \> 4 weeks[^a^](#TN1){ref-type="table-fn"}                        2, 87/87, 9.37 \[3.42, 15.33\], 83%                                                                                                   2, 87/87, −1.37 \[−2.09, −0.64\], 61%
  Reported appropriate randomized allocation methods[^b^](#TN2){ref-type="table-fn"}   4, 130/126, 7.00 \[3.81, 10.18\], 0%                                                                                                  4, 130/126, −1.50 \[−1.87, −1.13\], 0%

Subgroup analysis.

Sensitivity analysis.

*FMA, Fugl-Meyer Assessment; VAS, Visual Analog Scale*.

Sensitivity analysis was performed by only including studies that reported appropriate randomization sequence generation methods. The results were similar to that of the overall pool, with lower heterogeneity. The results also showed that acupuncture combined with routine rehabilitation produces better outcomes for FMA and VAS than rehabilitation alone ([Table 2](#T2){ref-type="table"}).

### Publication Bias

Publication bias was evaluated based on FMA and VAS, which were reported in 29 and 25 studies, respectively. Egger\'s test demonstrated there was no significant publication bias (FMA: *t* = −0.39, *P* = 0.702; VAS: *t* = 1.50, *P* = 0.147).

### Adverse Events

Thirty-three studies did not mention adverse events. Four studies reported that no adverse event occurred during the trials ([@B19], [@B36], [@B40], [@B42]). One RCT ([@B38]) described that three participants in the intervention group and two in the control group reported bruising after treatment. These events were considered to be mild and did not require any medical management. The study did not explore the causality of these adverse events ([@B38]).

### Assessment of Evidence

The evidence of all these outcomes was assessed as "low" certainty. The certainty of evidence was downgraded mainly due to the limitations in study design and inconsistency of results. The summary of finding table was presented in [Table 3](#T3){ref-type="table"}.

###### 

Certainty of evidence (GRADE).

  **Certainty assessment**   **№ of patients**   **Effect**                                **Certainty**                             **Importance**                                                                                                                                               
  -------------------------- ------------------- ----------------------------------------- ----------------------------------------- ---------------- ----------------------------------------- ------ ------- ------- ---- ---------------------------------------------------------- ---------- -----------
  **FMA UPPER LIMB**                                                                                                                                                                                                                                                                              
  29                         Randomized trials   Serious[^a^](#TN3){ref-type="table-fn"}   Serious[^b^](#TN4){ref-type="table-fn"}   Not serious      Not serious                               None   1,177   1,154   --   MD **8.01 higher** (6.69 higher to 9.33 higher)            ⊕⊕○○ LOW   Critical
  **VAS**                                                                                                                                                                                                                                                                                         
  25                         Randomized trials   Serious[^a^](#TN3){ref-type="table-fn"}   Serious[^b^](#TN4){ref-type="table-fn"}   Not serious      Not serious                               None   959     937     --   MD **1.59 lower** (1.86 lower to 1.32 lower)               ⊕⊕○○ LOW   Critical
  **ADL**                                                                                                                                                                                                                                                                                         
  11                         Randomized trials   Serious[^a^](#TN3){ref-type="table-fn"}   Serious[^b^](#TN4){ref-type="table-fn"}   Not serious      Not serious                               None   450     446     --   MD **9.99 higher** (5.91 higher to 14.06 higher)           ⊕⊕○○ LOW   Important
  **ROM Abduction**                                                                                                                                                                                                                                                                               
  3                          Randomized trials   Serious[^a^](#TN3){ref-type="table-fn"}   Not serious                               Not serious      Serious[^c^](#TN5){ref-type="table-fn"}   None   113     111     --   MD **11.94 degree higher** (9.44 higher to 14.45 higher)   ⊕⊕○○ LOW   Important

Lack of blinding of participants and personnel.

Substantial statistical heterogeneity.

Small sample size limits certainty of results.

*FMA, Fugl-Meyer Assessment; VAS, visual analog scale; ADL, activities of daily living; ROM, range of motion; Rehab, rehabilitation; CI, Confidence interval; MD, Mean difference; GRADE, The Grading of Recommendations Assessment, Development and Evaluation*.

Discussion {#s4}
==========

In this review, we identified 38 RCTs that evaluated the effects of adding acupuncture to routine rehabilitation to treat post-stroke SHS. Results showed that the combination of acupuncture and routine rehabilitation was superior to rehabilitation alone for improving motor function and ADL, and reducing pain. Manual and electro-acupuncture were both beneficial in the subgroup analysis. Further analysis of treatment duration did not indicate that treatment outcomes change with a long course of treatment (e.g., more than 4 weeks). The safety of acupuncture should be further validated, because most of the included studies did not mention adverse events. In addition, the overall "low" GRADE assessment results made our certainty in recommending this therapy to clinical practice as "low."

Manual and electro-acupuncture combined with routine rehabilitation improved FMA more than rehabilitation alone did. Moreover, the results reached the minimal clinical important difference (MCID) suggested by Page et al. ([@B55]) and Chen et al. ([@B56]) (5.2 and 4.58, respectively). Our results, based on 29 RCTs, confirmed the results of one previous systematic review ([@B12]) that evaluated FMA in six RCTs. Another previously published review ([@B14]) showed no benefit of acupuncture, however, the review only included two manual acupuncture RCTs in its meta-analysis. In contrast, our review included more studies with a larger sample size. It should also be noted that recent studies have sought to improve their methodology quality, with half of the included studies reporting appropriate randomization sequence generation. These will provide a greater certainty of the evidence of acupuncture\'s effect on motor function.

In terms of pain VAS, our review showed acupuncture combined with routine rehabilitation was much more effective than rehabilitation alone at reducing pain. These results are consistent with a recent systematic review of acupuncture for post-stroke shoulder pain ([@B57]). Furthermore, our review showed that manual and electro-acupuncture both help to relieve pain when used in combination with routine rehabilitation. This could reinforce the evidence for acupuncture in reducing pain associated with post-stroke SHS ([Table 2](#T2){ref-type="table"}).

The mechanism of how acupuncture relieves pain has been extensively studied. Electro-acupuncture alleviates sensory and affective inflammatory pain by acting through bioactive chemicals, including opioids, serotonin, and norepinephrine; glutamate receptors and transporters; cytokines; and signal molecules ([@B58]--[@B63]). With regard to how acupuncture helps to improve motor function, experimental studies indicate it may work by enhancing the gamma-aminobutyric acid receptor expression or promoting angiogenesis ([@B64], [@B65]). Currently, there is no consensus on the mechanism of acupuncture for SHS or CRPS, so further research is needed to investigate how acupuncture influences sympathetic/somatic nervous system dysfunction.

Study Strengths and Limitations
-------------------------------

Our systematic review has several strengths. First, we explored the effects of acupuncture for a specific complication (SHS) after stroke, rather than general motor function. Acupuncture points around the shoulder were the most frequently points used in treatment for SHS, which is consistent with two previous reviews ([@B57], [@B66]). These results may provide more focused evidence to improve clinical practice and health outcomes. Second, this systematic review was based on a comprehensive and up-to-date search of literature, with reliable evidence generated from analyses with large sample sizes. Third, subgroup analyses were conducted according to the type of acupuncture stimulation. Both electro-acupuncture and manual acupuncture were effective when they were used as add-on therapies. Fourth, validated outcome measures were selected to assess acupuncture\'s efficacy, which will also strengthen the reliability of our results.

However, some limitations of this review should be considered before its results can be translated to clinical practice. First, none of the studies used sham or placebo acupuncture in the control treatment. This means that the placebo effects of adding an intervention cannot be ruled out. In particular, Chinese populations usually have high expectations for acupuncture and this may have inflated treatment outcomes for the combined therapy. Second, the treatment duration and number of treatment sessions in the included studies varied greatly. Although we conducted a subgroup analysis based on treatment duration, the optimal duration, and number of treatment sessions are still unclear. Third, the included studies did not give enough information about the acupuncture parameters, such as depth of needle insertion and the acupuncturists\' backgrounds. This may affect the clinical implications of this research. Fourth, few studies reported adverse events, making it difficult for us to provide a conclusion about acupuncture\'s safe use in the management of post-stroke SHS. Moreover, none of the studies performed a long-term follow-up investigation of acupuncture, so it\'s unclear if acupuncture has a sustained effect on post-stroke SHS. Future clinical studies should include a sham/placebo control, a follow-up phase, and an in-depth data collection of adverse events.

Implication for Further Research
--------------------------------

All of the studies included in this review were conducted on mainland China. Further studies should be done around the world to involve more ethnically and culturally diverse populations. The methodological quality of future clinical trials should also be improved. In particular, double-blinding should be used where possible to avoid RCT performance bias. While it\'s difficult to have genuine double-blinding in acupuncture trials because acupuncturists have to be aware of the participants\' group allocation to treat them, participants can be blinded by using well-designed placebo acupuncture devices and sham acupuncture ([@B67], [@B68]). Outcome assessors can also be blinded. Finally, reports from future RCTs should follow the Consolidated Standards of Reporting Trials (CONSORT) statement and STRICTA checklists ([@B69], [@B70]).

Conclusion {#s5}
==========

This systematic review shows that adding acupuncture to routine rehabilitation can improve clinical outcomes (pain and motor function) for people with mild post-stroke SHS. However, the evidence was assessed as "low" by GRADE due to the methodological limitations and heterogeneity of included studies, which made our certainty in recommending acupuncture for this condition in clinical practice as "low." Well-designed placebo-controlled RCTs with a long treatment duration and follow up, as well as standardized reporting, are needed to support acupuncture\'s safe and effective use in the management of post-stroke SHS.
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